Non-alcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Non-alcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of Efimosfermin Alfa Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and White/European Ancestry [Phase 1]
A Phase 1 study to assess safety, tolerability, pharmacokinetics and immunogenicity of a single dose of Efimosfermin Alfa in healthy partici…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Target of Suv420h1/2 in Hepatocytes [NA]
A recruiting clinical trial is investigating inhibition of Suv420h1/2 in hepatocytes for non-alcoholic fatty liver disease.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Impact of Artificial Intelligence Algorithm-driven Versus Standard Lifestyle Intervention in Non-Alcoholic Fatty Liver Disease - A Multicenter, Randomized, Open-label, Controlled Trial [NA]
This clinical trial compares an artificial intelligence–driven lifestyle intervention to standard lifestyle recommendations for non-alcoholi…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Effects of Two Different Exercise Programs and Diet in Obese Subjects With NAFLD [NA]
This clinical trial update notes ongoing recruitment for a study comparing two exercise programs and dietary interventions in obese individu…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: EndoNAFLD: Relationship Between Fatty Liver Disease and Cardiovascular Diseases
A completed clinical trial examining the relationship between non-alcoholic fatty liver disease and cardiovascular diseases.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Effect of Patient Demographics, Comorbidities, and Medications on Severity of NASH Fibrosis
A completed clinical trial evaluating how patient demographics, comorbidities, and concomitant medications influence the severity of fibrosi…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
A recruiting clinical trial is examining the liver-gut axis by identifying liver disease–specific microbiome patterns. The study covers auto…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Simultaneous Quantification of Liver Fat Content, Fatty Acid Composition, and Fibrosis Using Spin-lock MRI for Steatohepatitis Assessment
Clinical trial update evaluating spin-lock MRI to simultaneously quantify liver fat content, fatty acid composition, and fibrosis for assess…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: The Efficacy and Safety of Ornithine Aspartic Acid Granules in NAFLD Against Silymarin Capsules [Phase 4]
Phase 4 trial comparing Ornithine Aspartic Acid Granules to Silymarin Capsules in non-alcoholic fatty liver disease completed, assessing eff…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Prevention of NAFLD in Hispanic Children [NA]
This is an update on an Emory University-sponsored clinical trial aimed at preventing non-alcoholic fatty liver disease in Hispanic children…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Efficacy and Safety of Picroliv in Patients With Non-Alcoholic Fatty Liver Disease [NA]
Clinical trial update evaluating the efficacy and safety of Picroliv in adults with non-alcoholic fatty liver disease, currently enrolling b…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Diagnosis of Fatty Liver With Outpatient Ultrasound
Recruiting is ongoing for a clinical study evaluating outpatient ultrasound to diagnose fatty liver (liver steatosis).
-
CLINICAL_TRIALS withdrawal · 2026-03-11Clinical Trial Update: Assessment of Fatty Liver With Thermo-acoustic Device
A clinical trial evaluating a thermo-acoustic device for fatty liver diseases has been withdrawn.
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: GLP-1 RA on Liver OMICS in MASLD
This clinical trial update describes a study evaluating GLP-1 receptor agonists on liver omics in MASLD/NAFLD, with recruitment not yet star…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With NAFLD
This completed clinical trial evaluated the relationship between hepatic fibrosis and cardiovascular risk in patients with non-alcoholic fat…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Effects of Short-Term Resistance Training on Diaphragm Thickness, Hepatic Fat Density, and Quality of Life in Healthy Older Men [NA]
This clinical trial update reports a completed study investigating the effects of short-term resistance training on diaphragm thickness, hep…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: The Effects of Glucagon on Hepatic Metabolism [Phase 1, Phase 2]
This clinical trial update notes ongoing Phase 1 and Phase 2 studies of glucagon's effects on hepatic metabolism in obesity, Type 2 diabetes…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Endoscopic Ultrasound Shear Wave Elastography in Patients With Non-alcoholic Fatty Liver Disease
This clinical trial evaluates endoscopic ultrasound shear wave elastography as a diagnostic method in patients with non-alcoholic fatty live…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease [NA]
This clinical trial investigates how diet and meal timing affect patients with Non-Alcoholic Fatty Liver Disease (metabolic dysfunction-asso…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Effect of Electroacupuncture on Central Obesity and Fatty Liver in Postmenopausal Women [NA]
This clinical trial is evaluating whether electroacupuncture can reduce central obesity and fatty liver in postmenopausal women, and it is n…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Placenta Hydrolysate) is to Evaluate the Efficacy and Safety of Intravenous Drop [Phase 3]
Phase 3 trial updating that LAENNEC (human placenta hydrolysate) is being evaluated for efficacy and safety when given as an intravenous inf…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Identification of Liver Fibrosis Biomarkers
Clinical trial update about identifying biomarkers for liver fibrosis in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis…
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASH [Phase 1, Phase 2]
A completed phase 1/2 clinical trial sponsored by Chuncheon Sacred Heart Hospital evaluated the effects of probiotic strains Pediococcus pen…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Comorbidities Resolution After MGB Surgery and Change in Body Composition
This clinical trial evaluates resolution of obesity-related comorbidities and changes in body composition after mini-gastric bypass surgery …
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Randomized, Double-blind, Single-center Phase I/IIa Study of XTYW007 Tablets in Subjects. [EARLY_Phase 1]
An early-phase, randomized, double-blind study of XTYW007 tablets for non-alcoholic fatty liver disease, currently not recruiting.